Brian Pacampara, CFA
Brian Pacampara, CFA
Content StrategistBrian is an editor for Moneywise. A long-time stock junkie, his work has appeared in The Motley Fool, Seeking Alpha, and Yahoo Finance. He believes in owning "Forever Stocks" — a rare group of businesses that have paid out dividends for decades. Brian holds the Chartered Financial Analyst (CFA) designation.
Brian is the investing editor at Moneywise. A long-time stock junkie, his work has appeared in The Motley Fool, Seeking Alpha, and Yahoo Finance. He believes in owning "forever stocks" — from a rare group of businesses that have paid out dividends for decades. Brian holds the Chartered Financial Analyst (CFA) designation.
Brian Pacampara, CFA's Expertise
More from Brian Pacampara, CFA
LATEST
Investing • May 26
Ford shares could soar 70% in the next year
Ford has been walloped. But this Wall Street firm says it has the gas to come back strong.
Investing • May 26
Ford shares could soar 70% in the next year
Ford has been walloped. But this Wall Street firm says it has the gas to come back strong.
Investing • May 23
Investing 101: A beginner's guide
Find answers to some of the most frequently asked questions when it comes to investing and investments.
Investing • May 23
Investing 101: A beginner's guide
Find answers to some of the most frequently asked questions when it comes to investing and investments.
Investing • Feb 01
Cash kings sitting in Warren Buffett's portfolio
These companies produce the only thing that matters.
Investing • Feb 01
Cash kings sitting in Warren Buffett's portfolio
These companies produce the only thing that matters.
Investing • Jan 05
Jim Cramer: 2022 Is the Year to Invest in Companies That Actually Make Money — And These 3 Stocks Fit the Bill
It's time to abandon today’s obsession with empty growth, the CNBC host says.
Investing • Jan 05
Jim Cramer: 2022 Is the Year to Invest in Companies That Actually Make Money — And These 3 Stocks Fit the Bill
It's time to abandon today’s obsession with empty growth, the CNBC host says.
Investing • Sep 21
Cathie Wood holds these stocks for big upside
These stocks are all about the big payoff.
Investing • Sep 21
Cathie Wood holds these stocks for big upside
These stocks are all about the big payoff.
Investing • Sep 20
Warren Buffett Says These Are the Best Businesses
Stop losing money on mediocre businesses.
Investing • Sep 20
Warren Buffett Says These Are the Best Businesses
Stop losing money on mediocre businesses.
Investing • Sep 13
Cash kings sitting in Warren Buffett's portfolio
These companies produce the only thing that matters.
Investing • Sep 13
Cash kings sitting in Warren Buffett's portfolio
These companies produce the only thing that matters.
Investing • Aug 31
Warren Buffett is holding these 3 income stocks
Warren Buffett still likes these high-yield plays — maybe you should too.
Investing • Aug 31
Warren Buffett is holding these 3 income stocks
Warren Buffett still likes these high-yield plays — maybe you should too.
Investing • Aug 19
What is global investing?
Going international is easier than ever, so there's no need to limit your options.
Investing • Aug 19
What is global investing?
Going international is easier than ever, so there's no need to limit your options.
Investing • Aug 17
Oil Prices Slump: Fat 5%+ Yields on Exxon, Chevron and BP Now Available
Recent oil price weakness could be an income opportunity.
Investing • Aug 17
Oil Prices Slump: Fat 5%+ Yields on Exxon, Chevron and BP Now Available
Recent oil price weakness could be an income opportunity.
Investing • Aug 14
Disney Pops, Moderna Drops, and WISH Flops: 3 Key Lessons From Wall Street
Yesterday's market is today's wealth-building road map.
Investing • Aug 14
Disney Pops, Moderna Drops, and WISH Flops: 3 Key Lessons From Wall Street
Yesterday's market is today's wealth-building road map.
Investing • Aug 13
Forget Moderna! 3 Lower-Volatility Stocks for the Post-COVID Recovery
3 non-pharmaceutical stocks for the post-covid recovery.
Investing • Aug 13
Forget Moderna! 3 Lower-Volatility Stocks for the Post-COVID Recovery
3 non-pharmaceutical stocks for the post-covid recovery.
Explore more authors
We’re proud of our contributors, and can’t wait for you to meet them.
Chris Clark
Freelance Writer
Emma Johnston-Wheeler
Staff Writer
Norma Spencer
null
Erin Gobler
Contributor